Researchers at the University of B.C. say they’ve averted a looming medical isotope shortage by proving they can produce enough of the chemical element used in life-saving cardiac and cancer scans to stop using nuclear plants.
The breakthrough research means aging nuclear power plants — plagued with leaks, high maintenance costs and problems disposing toxic waste — will likely be replaced with cyclotrons, a particle accelerator the size of an SUV, in hospitals starting as early as next year.
A team including UBC scientists has been working on finding a solution for more than five years, and TRIUMF, Canada’s national laboratory for particle and nuclear physics, announced last year that it had found an alternative by using cyclotron-based production of isotopes.
Now UBC says the cyclotron has produced enough isotopes in six hours to conduct about 500 scans — beating the previous record almost fourfold. It was the amount needed to prove that this could be a practical solution for the looming national threat of a medical isotope shortage.
The aging National Research Universal Reactor near Chalk River, Ont., is set to retire in 2016. It produces the country’s main source of medical isotopes, technetium 99m (Tc99m) — a diagnostic isotope used in medical scans.
Cyclotron-based production of Tc99m would provide a solution to shift away from reactor based production of isotopes, while providing a safe and secure supply for Canadian patients, the researchers say.
Read more: Breakthrough UBC research finds cleaner, safer source of medical isotopes than nuclear power plants
The Latest on: Medical isotopes
[google_news title=”” keyword=”Medical isotopes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Medical isotopes
- Cambridge Isotope Laboratories, Inc.: Cambridge Isotope Laboratories Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchaseon April 25, 2024 at 6:17 am
TEWKSBURY, MA / ACCESSWIRE / April 25, 2024 / Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location.
- Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchaseon April 25, 2024 at 2:00 am
TEWKSBURY, MA / ACCESSWIRE / April 25, 2024 / Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location.
- Framatome and KHNP to assess feasibility of medical isotope production at Wolsongon April 24, 2024 at 8:52 am
Framatome Healthcare, through its Isogen joint venture with Canada's Kinectrics, was involved in an international collaboration with Bruce Power and ITM Isotope Technologies Munic SE to produce ...
- Carbon-14 radioactive isotope enters mass production in Chinaon April 22, 2024 at 7:26 am
The mass production of carbon-14, as reported by state media’s China Science Daily, is being done at a commercial nuclear reactor in the eastern province of Zhejiang.
- China passes mass production milestone in carbon-14 isotope outputon April 21, 2024 at 2:59 pm
Qinshan Nuclear Power Plant in Zhejiang expected to be able to make enough of the material to meet the country’s demand.
- China starts mass production of carbon-14 isotope at commercial nuclear reactor: Reporton April 21, 2024 at 8:17 am
The Chinese government has said that the mass production of carbon-14 isotope from this nuclear plant should completely fulfil China’s demand and finish the country’s reliance on imports ...
- China achieves domestic production of carbon-14 isotopes, breaking import dependenceon April 21, 2024 at 6:07 am
China has achieved the mass production of carbon-14 isotopes by using a commercial nuclear reactor, the China National Nuclear Corporation (CNNC) told the Global Times on Sunday. Experts noted that ...
- Global Medical Isotope Market Will Grow Steadily, Driven By Increasing Demand For Nuclear Medicine Procedureson April 21, 2024 at 5:02 am
According to SNS Insider, the Canada Medical Isotopes Market is expected to grow at a CAGR of 11.8% over the forecast period of 2024 -2031, the valuation estimated to hit $2223.99 Mn by 2031. Medical ...
- South Korean Nuclear Power Plant Will Assess Feasibility of Medical Isotope Productionon April 17, 2024 at 3:31 pm
Framatome and Korea Hydro & Nuclear Power (KHNP) have signed a memorandum of understanding (MoU) to demonstrate the feasibility of producing non-carrier added lutetium-177, a medical isotope used for ...
- B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisitionon April 11, 2024 at 11:30 am
A West Coast life sciences firm known for whipping up medical isotopes has whipped up a sizeable asking price for its sale. Australia’s Telix Pharmaceuticals Ltd. announced Thursday (April 11) the ...
via Bing News